Abstract
AbstractThe compounds (VI) are tested in vitro for their anti‐inflammatory activity through the inhibition of the necrosis factor alpha production (TNF‐α) in lipopolysaccharide (LPS)‐activated human peripheral blood monocular cells (hPBMC).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have